Inventor
GARCIA RUBIO SILVINA
US17 patents
⚠️ This page may combine multiple inventors who share the name “GARCIA RUBIO SILVINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HELSINN HEALTHCARE SA
16 patentsUS9403867B2Aug 2, 2016
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA9 citations90
US9981002B2May 29, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US9956261B2May 1, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US9872883B2Jan 23, 2018
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA3 citations82
US10407390B2Sep 10, 2019
Asymmetric ureas and medical uses thereof
HELSINN HEALTHCARE SA1 citations72
US10577384B2Mar 3, 2020
Substituted asymmetric ureas as modulators of ghrelin receptor activity
HELSINN HEALTHCARE SA2 citations71
US10300105B2May 28, 2019
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA1 citations71
US9926337B2Mar 27, 2018
Substituted asymmetric ureas as modulators of ghrelin receptor activity
HELSINN HEALTHCARE SA2 citations71
US9546157B2Jan 17, 2017
Asymmetric piperidinyl-substituted ureas as medicines
HELSINN HEALTHCARE SA4 citations71
US12005056B2Jun 11, 2024
Centrally-active ghrelin agonist and medical uses thereof
HELSINN HEALTHCARE SA2 citations69
US10905737B2Feb 2, 2021
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA0 citations60
US12440485B2Oct 14, 2025
Centrally-active ghrelin agonist and medical uses thereof
HELSINN HEALTHCARE SA0 citations59
US11884646B2Jan 30, 2024
Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereof
HELSINN HEALTHCARE SA0 citations59
US11299472B2Apr 12, 2022
Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof
HELSINN HEALTHCARE SA0 citations59
US9751836B2Sep 5, 2017
Asymmetric ureas and medical uses thereof
HELSINN HEALTHCARE SA0 citations51
US10576122B2Mar 3, 2020
Methods of producing anamorelin hydrochloride having controlled chloride content
HELSINN HEALTHCARE SA0 citations50